Heat-treated IgM antibody preparations
AssigneeBayer Aktiengesellschaft
InventorsGrace C. Tsay, Gary Jesmok
Life of this patent
Estimating the term…
Abstract
Mild heat-treatment of IgM antibody concentrates diminishes the potential to induce non-specific complement activation without significant loss of normal immunologic effector functions. These IgM immunoglobulin concentrates retain specific antigen binding properties and activate complement when bound to antigen. Preferred product includes at least 20% by weight IgM in an IgM/IgG antibody mixture. Heating is done at a temperature within the range of about 40.degree. C. to 62.degree. C., preferably about 45.degree. to 55.degree. C., in a solution having an acid pH (preferably 4.0 to 5.0) for at least about 10 minutes.
Claims5
An antibody preparation comprising antibodies of the IgM type wherein said antibodies of the IgM type comprise at least about 20% by weight of the total amount of antibodies the preparation having the characteristics of generating non-specific complement activation of less than about 1.0 ug/ml C4.sub.a in an in vitro assay while being capable of generating specific complement activating activity.
In an antibody preparation comprising biologically active antibodies of the IgM and IgG types, the improvement comprising the characteristics of
- (A) comprising IgM antibodies in an amount of at least about 20% by weight of the total amount of antibodies;
- (B) generating non-specific complement activation of less than about 1.0 ug/ml C4a in an in vitro assay, and
- (C) retaining antigen binding and specific complement activating activity.
The preparation of claim 5 wherein the IgM comprises at least about 30% by weight of the total amount of antibodies.
Dependencies are inferred from the claim text.